(Q53160358)

English

Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.

scientific article published on 28 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

chemoradiotherapy

0 references

author name string

Shu-Wen Jao

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Su-Feng Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Yaoh-Shiang Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Yun-Ching Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Tsai-Yu Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Chang-Chieh Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Jong-Shiaw Jin

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Shin Nieh

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

publication date

28 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

19

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

3432-3440

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

https://scigraph.springernature.com/pub.10.1245/s10434-012-2394-3

0 references

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell-directed therapies: recent data from the laboratory and clinic

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Modern management of rectal cancer: a 2006 update

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Applying the principles of stem-cell biology to cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Mechanisms controlling pathogenesis and survival of leukemic stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Tumor markers and colorectal cancer: utility in management

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Leukocyte polarization in cell migration and immune interactions

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Identifiers

10.1245/S10434-012-2394-3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53160358&oldid=1189346304"